ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för safranal. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

27 träffar

Bibliografisk träff 2025-07-02

The impact of gamma and electron beam irradiation sterilization technology on the pigments and phenolic components of saffron.

Reshad M, Shirmardi SP, Afarideh H, Shahbazi S, Askari H.

Sci Rep · research-article; journal article · DOI 10.1038/s41598-025-08136-6

Bibliografisk träff 2025-06-16

Safranal Alleviates Cyclophosphamide Induced Testicular Toxicity in Rats.

Cellat M, Yavaş İ, Uyar A, Etyemez M, Güvenç M.

Food Sci Nutr · research-article; journal article · DOI 10.1002/fsn3.70452

Bibliografisk träff 2025-05-19

Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/β-catenin pathway.

Samra YA, Abd El Salam ASG, Abdelghany AM, El-Shishtawy MM.

Discov Oncol · research-article; journal article · DOI 10.1007/s12672-025-02447-w

Bibliografisk träff 2025-05-14

Safranal ameliorates atherosclerosis progression partly via repressing PI3K/Akt and NF-κB signaling pathways in ApoE (-/-) mice.

Geng Y, Song M, Huang B, Lin R, Wu S, Lin A.

J Nat Med · journal article · DOI 10.1007/s11418-025-01913-7

Bibliografisk träff 2025-03-31

Safranal restores RUNX3-mediated immunoregulation by inhibiting the NLRP3 inflammasome in allergic asthma.

Zhang X, Li X, Wang P, Zhao S, Zhao Y.

Naunyn Schmiedebergs Arch Pharmacol · journal article · DOI 10.1007/s00210-025-03943-0

Bibliografisk träff 2025-03-04

Safranal Ameliorates Renal Damage, Inflammation, and Podocyte Injury in Membranous Nephropathy via SIRT/NF-κB Signalling.

Bao Y, Ge YM, Wang Z, Wang HY, Wang Q, Yuan J.

Curr Med Sci · research-article; journal article · DOI 10.1007/s11596-025-00020-8

Bibliografisk träff 2024-12-30

Safranal ameliorates testicular ischemia-reperfusion injury in testicular torsion-detorsion rat model.

Wei SM, Huang YM.

Rev Int Androl · research support, non-u.s. gov't; journal article · DOI 10.22514/j.androl.2024.028

Bibliografisk träff 2024-12-29

Micromeria barbata for targeting MRSA virulence: In silico and in vitro studies.

Rawas S, Al Hakawati N, Mcheik A, El S El Badan D.

Heliyon · research-article; journal article · DOI 10.1016/j.heliyon.2024.e41536

Bibliografisk träff 2024-11-19

Ultrasound treatment on saffron (Crocus sativus L.) corm: Impact on textural, morphological, and microbial properties and stigma- derived metabolite compositions.

Razavizadeh BM, Ziaratnia SM.

Heliyon · research-article; journal article · DOI 10.1016/j.heliyon.2024.e40548

Bibliografisk träff 2024-06-17

Interaction of major saffron constituent safranal with trypsin: An experimental and computational investigation.

Ali MS, Teixeira LMC, Ramos MJ, Fernandes PA, Al-Lohedan HA.

Int J Biol Macromol · journal article · DOI 10.1016/j.ijbiomac.2024.133231

Bibliografisk träff 2024-05-31

Safranal alleviates pentetrazole-induced epileptic seizures in mice by inhibiting the NF-κB signaling pathway and mitochondrial-dependent apoptosis through GSK-3β inactivation.

Yan J, Li T, Ji K, Zhou X, Yao W, Zhou L, Huang P, Zhong K.

J Ethnopharmacol · journal article · DOI 10.1016/j.jep.2024.118408

Bibliografisk träff 2024-04-29

Safranal exerts a neuroprotective effect on Parkinson's disease with suppression of NLRP3 inflammation activation.

Yang W, Wei Y, Sun J, Yao C, Ai F, Ding H.

Mol Biol Rep · research-article; journal article · DOI 10.1007/s11033-024-09537-y

Bibliografisk träff 2024-01-15

The CB1 cannabinoid receptors involvement in anti-epileptic effect of safranal on penicillin-induced epileptiform activity in rats.

Tamaddonfard S, Erfanparast A, Tamaddonfard E, Soltanalinejad F.

Vet Res Forum · research-article; journal article · DOI 10.30466/vrf.2023.2000166.3851

Bibliografisk träff 2024-01-12

Proteomic and molecular analyses to understand the promotive effect of safranal on soybean growth under salt stress.

Kausar R, Nishiuchi T, Komatsu S.

J Proteomics · journal article · DOI 10.1016/j.jprot.2024.105072

Bibliografisk träff 2024-01-01

Effects of Crocus sativus and its constituent, safranal, and pioglitazone, on systemic inflammation and oxidative stress induced by paraquat aerosol in rats.

Memarzia A, Ghasemi SZ, Amin F, Gholamnezhad Z, Boskabady MH.

Iran J Basic Med Sci · research-article; journal article · DOI 10.22038/ijbms.2024.72996.15867

Bibliografisk träff 2023-12-19

Safranal acts as a neurorestorative agent in rats with cerebral ischemic stroke via upregulating SIRT1.

He F, Chen C, Wang Y, Wang S, Lyu S, Jiao J, Huang G, Yang J.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2023.12358

Bibliografisk träff 2023-11-15

Interaction between the antioxidant compound safranal and α-chymotrypsin in spectroscopic fields and molecular modeling approaches.

Zohreh Vahedi S, Farhadian S, Shareghi B, Asgharzadeh S.

J Biomol Struct Dyn · research support, non-u.s. gov't; journal article · DOI 10.1080/07391102.2023.2272186

Bibliografisk träff 2023-11-01

Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.

Shehata NI, Abd El-Salam DM, Hussein RM, Rizk SM.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0293660

Bibliografisk träff 2023-09-05

Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM).

Yang X, Lu D, Sun Y, Wei T, Man D, Chen A, Luo T, Zhao F, Liu X, Cheng B, Wang X, Zhao P, Wang D, Li X.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2023.1255164

Bibliografisk träff 2023-01-01

Neuroprotective Potency of Safranal Against Neurological Disorders.

Fazeli E, Ghalibaf MHE, Forouzanfar F.

Curr Mol Med · review; journal article · DOI 10.2174/1566524023666221117104612

Bibliografisk träff 2023-01-01

Pharmacological effects of Safranal: An updated review.

Esmaealzadeh D, Moodi Ghalibaf A, Shariati Rad M, Rezaee R, Razavi BM, Hosseinzadeh H.

Iran J Basic Med Sci · review-article; review; journal article · DOI 10.22038/ijbms.2023.69824.15197

Bibliografisk träff 2022-12-07

Interactions of Apigenin and Safranal with the 5HT1A and 5HT2A Receptors and Behavioral Effects in Depression and Anxiety: A Molecular Docking, Lipid-Mediated Molecular Dynamics, and In Vivo Analysis.

Amin F, Ibrahim MAA, Rizwan-Ul-Hasan S, Khaliq S, Gabr GA, Muhammad, Khan A, Sidhom PA, Tikmani P, Shawky AM, Ahmad S, Abidi SH.

Molecules · research-article; journal article · DOI 10.3390/molecules27248658

Bibliografisk träff 2021-10-17

Unifloral Autumn Heather Honey from Indigenous Greek Erica manipuliflora Salisb.: SPME/GC-MS Characterization of the Volatile Fraction and Optimization of the Isolation Parameters.

Xagoraris M, Chrysoulaki F, Revelou PK, Alissandrakis E, Tarantilis PA, Pappas CS.

Foods · research-article; journal article · DOI 10.3390/foods10102487

Bibliografisk träff 2021-06-29

Partial Characterization of the Impact of Saffron on the Sensory and Physicochemical Quality Traits of Dry-Cured Ham.

Gómez-Sáez EM, Moratalla-López N, Alonso GL, Vergara H.

Foods · research-article; journal article · DOI 10.3390/foods10071506

Bibliografisk träff 2021-02-25

Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?

Pitsikas N.

Molecules · review-article; review; journal article · DOI 10.3390/molecules26051237

Bibliografisk träff 2020-12-16

Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-Associated Protein 2.

Jiang X, Li Y, Feng JL, Nik Nabil WN, Wu R, Lu Y, Liu H, Xi ZC, Xu HX.

Front Cell Dev Biol · research-article; journal article · DOI 10.3389/fcell.2020.598620

Bibliografisk träff 2020-03-02

RIFM fragrance ingredient safety assessment, 2,6,6-trimethylcyclohexa-1,3-dienyl methanal, CAS Registry Number 116-26-7.

Api AM, Belsito D, Biserta S, Botelho D, Bruze M, Burton GA, Buschmann J, Cancellieri MA, Dagli ML, Date M, Dekant W, Deodhar C, Fryer AD, Gadhia S, Jones L, Joshi K, Lapczynski A, Lavelle M, Liebler DC, Na M, O'Brien D, Patel A, Penning TM, Ritacco G, Rodriguez-Ropero F, Romine J, Sadekar N, Salvito D, Schultz TW, Siddiqi F, Sipes IG, Sullivan G, Thakkar Y, Tokura Y, Tsang S.

Food Chem Toxicol · review; journal article · DOI 10.1016/j.fct.2020.111233

Gå till forskningen.

Publikationer i urvalet

The impact of gamma and electron beam irradiation sterilization technology on the pigments and phenolic components of saffron.

Safranal Alleviates Cyclophosphamide Induced Testicular Toxicity in Rats.

Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/β-catenin pathway.

Safranal ameliorates atherosclerosis progression partly via repressing PI3K/Akt and NF-κB signaling pathways in ApoE (-/-) mice.

Safranal restores RUNX3-mediated immunoregulation by inhibiting the NLRP3 inflammasome in allergic asthma.

Safranal Ameliorates Renal Damage, Inflammation, and Podocyte Injury in Membranous Nephropathy via SIRT/NF-κB Signalling.

Safranal ameliorates testicular ischemia-reperfusion injury in testicular torsion-detorsion rat model.

<i>Micromeria barbata</i> for targeting MRSA virulence: <i>In silico</i> and <i>in vitro</i> studies.

Ultrasound treatment on saffron <i>(Crocus sativus</i> L<i>.)</i> corm: Impact on textural, morphological, and microbial properties and stigma- derived metabolite compositions.

Interaction of major saffron constituent safranal with trypsin: An experimental and computational investigation.

Safranal alleviates pentetrazole-induced epileptic seizures in mice by inhibiting the NF-κB signaling pathway and mitochondrial-dependent apoptosis through GSK-3β inactivation.

Safranal exerts a neuroprotective effect on Parkinson's disease with suppression of NLRP3 inflammation activation.

The CB1 cannabinoid receptors involvement in anti-epileptic effect of safranal on penicillin-induced epileptiform activity in rats.

Proteomic and molecular analyses to understand the promotive effect of safranal on soybean growth under salt stress.

Effects of <i>Crocus sativus</i> and its constituent, safranal, and pioglitazone, on systemic inflammation and oxidative stress induced by paraquat aerosol in rats.

Safranal acts as a neurorestorative agent in rats with cerebral ischemic stroke via upregulating SIRT1.

Interaction between the antioxidant compound safranal and α-chymotrypsin in spectroscopic fields and molecular modeling approaches.

Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.

Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM).

Neuroprotective Potency of Safranal Against Neurological Disorders.

Pharmacological effects of Safranal: An updated review.

Interactions of Apigenin and Safranal with the 5HT1A and 5HT2A Receptors and Behavioral Effects in Depression and Anxiety: A Molecular Docking, Lipid-Mediated Molecular Dynamics, and In Vivo Analysis.

Unifloral Autumn Heather Honey from Indigenous Greek <i>Erica manipuliflora</i> Salisb.: SPME/GC-MS Characterization of the Volatile Fraction and Optimization of the Isolation Parameters.

Partial Characterization of the Impact of Saffron on the Sensory and Physicochemical Quality Traits of Dry-Cured Ham.

<i>Crocus sativus</i> L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?

Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells <i>via</i> Downregulation of S-Phase Kinase-Associated Protein 2.

RIFM fragrance ingredient safety assessment, 2,6,6-trimethylcyclohexa-1,3-dienyl methanal, CAS Registry Number 116-26-7.